RxDoctor Payments Data

Therese Defabis, APRN

Adult Health · Lebanon, INNPI 1538250618

Payments from drug & device makers

$829in general payments, 2019–2025

Across 36 payments — averaging $23.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$214
  • Abbott$181
  • Exact Sciences$157
  • Pfizer$136
  • Dexcom, Inc.$56
  • AbbVie$53
  • plus $32 from 2 others

What the payments were for

  • Food & beverage$829100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$829 in reported general payments places this provider in the 60th percentile of 391 adult health providers in Indiana.

See all adult health providers in Indiana

Medicare billing

Part B allowed, 2024
$71,384
Medicare patients
148
Services billed
1,466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide111$120,717
EliquisApixaban107$78,234
JardianceEmpagliflozin71$53,936
LinzessLinaclotide67$39,004
Trelegy ElliptaFluticasone/Umeclidin/Vilanter59$37,598
TrulicityDulaglutide23$20,425
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen233$7,330
SymbicortBudesonide/Formoterol Fumarate17$6,150
FarxigaDapagliflozin Propanediol11$6,003
Morphine Sulfate ErMorphine Sulfate12$5,617
Dexlansoprazole DrDexlansoprazole27$5,466
Incruse ElliptaUmeclidinium Bromide14$5,228
Levothyroxine Sodium473$4,136
Atorvastatin Calcium441$3,896
Icosapent Ethyl13$3,593

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$136$78,234107 claims
GSKTrelegy Ellipta, Incruse Ellipta, Shingrix$214$45,72686 claims
AbbVieLinzess, Synthroid$53$41,798108 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 391 adult health providers in Indiana.

Other adult health in Lebanon

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →